General Info
What is Thrombophilia? A Comprehensive Guide
Thrombophilia is a condition in which blood clots more easily than normal. Inherited and acquired types, risk factors, symptoms, diagnosis and management are covered in this guide.
9 min · 15 January 2025
Thrombophilia is an inherited or acquired condition in which blood clots more easily than normal inside the vessels. The clotting system is a complex cascade that stops bleeding; in thrombophilia this balance tips toward clot formation. The key question: does every carrier experience a clot? No. Many carriers never have a problem — but risk rises sharply under certain conditions.
How Does Blood Clotting Work?
Coagulation is a cascade of proteins that seals vessel injuries. The system includes both pro-clotting factors and natural inhibitors that limit and dissolve clots (Protein C, Protein S, Antithrombin, fibrinolysis). Thrombophilia disturbs this balance in two ways: mutations that over-activate clotting factors (Factor V Leiden, Prothrombin G20210A) or deficiencies of the natural inhibitors (Protein C/S, Antithrombin deficiency).
Inherited Thrombophilia Types
- Factor V Leiden (FVL): The most common inherited thrombophilia worldwide; heterozygous carrier frequency is roughly 5-8% in European populations. It makes Factor V resistant to Protein C breakdown.
- Prothrombin G20210A mutation: Raises prothrombin (Factor II) levels; heterozygous frequency around 2-3%.
- MTHFR variants: Affect homocysteine metabolism. Homozygous C677T may cause mild hyperhomocysteinemia; its thrombosis association is weaker and must be interpreted clinically.
- Protein C, Protein S and Antithrombin deficiencies: Rarer but higher-risk natural inhibitor deficiencies.
- Combined thrombophilia: Carrying multiple mutations (e.g. FVL + PT) can multiply risk.
Acquired Thrombophilia
The most significant acquired cause is antiphospholipid syndrome (APS) — associated with recurrent thrombosis and pregnancy loss and carrying a risk high enough to require anticoagulation. Pregnancy, estrogen-containing contraceptives, hormone therapy, prolonged immobility, major surgery, cancer and obesity also raise acquired risk.
Symptoms and Complications
Thrombophilia itself is silent; what manifests is the actual thrombotic event:
- Deep vein thrombosis (DVT): Usually unilateral leg swelling, pain, redness and warmth.
- Pulmonary embolism (PE): Sudden shortness of breath, chest pain, palpitations, hemoptysis — an emergency.
- Pregnancy complications: Recurrent miscarriage, preeclampsia, placental abruption, preterm birth and fetal growth restriction.
Who Should Get Tested?
Anyone with unexplained thrombosis under 45, recurrent pregnancy loss, family history of early thrombosis, clots in unusual sites (mesenteric, cerebral veins) and high-risk individuals planning estrogen therapy form the main target group. The test decision is made by a physician weighing personal and family history.
The Diagnostic Process
At our laboratory, DNA is isolated from a small blood sample; Factor V Leiden (G1691A), Prothrombin (G20210A) and MTHFR (C677T/A1298C) variants are analyzed by PCR and real-time methods. Protein C, S and Antithrombin levels can be added to the same panel. Results are delivered in 7-10 business days as a detailed report including mutation status and clinical recommendations.
What Early Diagnosis Provides
Knowing your risk makes planning easier: preconception counseling, perioperative prophylaxis planning, travel precautions and family screening. Lifestyle measures — healthy weight, regular exercise, smoking cessation, avoiding prolonged immobility — are the foundation for every carrier.
Conclusion
Thrombophilia is a manageable risk profile when you understand it. A positive result is not a disease but a risk marker; treatment is a personalized decision your physician makes based on your thrombosis history. Contact our expert team with any questions.